Clinical Trial

Spondylo-arthritis Screening Tool Among Patient Suffering From Inflammatory Bowel Disease

Study acronym: QUESAM
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 31, 2025 (before its estimated April 2026 completion). Its status may not reflect the trial's current state.
Summary
The QUESAM study aims to translate into French and validate the traduction of 2 screening questionnaires for spondylo-arthritis among people with inflammatory bowel disease. DETAIL (DETection of Arthritis in Inflammatory boweL diseases) and IBIS-Q (Inflammatory Bowel disease Identification of Spondyloarthritis Questionnaire) questionnaires are built to determine which patients might benefit from a rheumatologic consultation, for a potential rheumatologic inflammatory disease. The investigators will translate the 2 questionnaire in french thanks to an external translation company, from english to french, then back to english to make sure the translation is correct. Then, the main question is: is there a conceptual and semantic equivalence beetween the original english questionnaire and the french-translated one. Participant will answer the 2 screening questionnaire, one initial time during a consultation, and a second time after 1 month.
Trial Details
NCT Number NCT06998316
Lead Sponsor University Hospital, Grenoble
Collaborators: Clinique des Cèdres, Echirolles
Conditions Spondylarthritis, Inflammatory Bowel Diseases, Crohn Disease, Ulcerative Colitis, Spondylitis, Ankylosing
Enrollment 220 participants
Start Date 2025-05
Primary Completion 2026-04 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2025-05-31